Skip to main content

Table 2 15-mer cyclin D1 overlapping library

From: A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40

Peptide

Position

Sequence

Peptide

Position

Sequence

Peptide

Position

Sequence

1

1–15

MEHQLLCCEVETIRR

26

101–115

LLGATCMFVASKMKE

51

201–215

SMVAAGSVVAAVQGL

2

5–19

LLCCEVETIRRAYPD

27

105–119

TCMFVASKMKETIPL

52

205–219

AGSVVAAVQGLNLRS

3

9–23

EVETIRRAYPDANLL

28

109–123

VASKMKETIPLTAEK

53

209–223

VAAVQGLNLRSPNNF

4

13–27

IRRAYPDANLLNDRV

29

113–127

MKETIPLTAEKLCIY

54

213–227

QGLNLRSPNNFLSYY

5

17–31

YPDANLLNDRVLRAM

30

117–131

IPLTAEKLCIYTDNS

55

217–231

LRSPNNFLSYYRLTR

6

21–35

NLLNDRVLRAMLKAE

31

121–135

AEKLCIYTDNSIRPE

56

221–235

NNFLSYYRLTRFLSR

7

25–39

DRVLRAMLKAEETCA

32

125–139

CIYTDNSIRPEELLQ

57

225–239

SYYRLTRFLSRVIKC

8

29–43

RAMLKAEETCAPSVS

33

129–143

DNSIRPEELLQMELL

58

229–243

LTRFLSRVIKCDPDC

9

33–47

KAEETCAPSVSYFKC

34

133–147

RPEELLQMELLLVNK

59

233–247

LSRVIKCDPDCLRAC

10

37–51

TCAPSVSYFKCVQKE

35

137–151

LLQMELLLVNKLKWN

60

237–251

IKCDPDCLRACQEQI

11

41–55

SVSYFKCVQKEVLPS

36

141–155

ELLLVNKLKWNLAAM

61

241–255

PDCLRACQEQIEALL

12

45–59

FKCVQKEVLPSMRKI

37

145–159

VNKLKWNLAAMTPHD

62

245–259

RACQEQIEALLESSL

13

49–63

QKEVLPSMRKIVATW

38

149–163

KWNLAAMTPHDFIEH

63

249–263

EQIEALLESSLRQAQ

14

53–67

LPSMRKIVATWMLEV

39

153–167

AAMTPHDFIEHFLSK

64

253–267

ALLESSLRQAQQNMD

15

57–71

RKIVATWMLEVCEEQ

40

157–171

PHDFIEHFLSKMPEA

65

257–271

SSLRQAQQNMDPKAA

16

61–75

ATWMLEVCEEQKCEE

41

161–175

IEHFLSKMPEAEENK

66

261–275

QAQQNMDPKAAEEEE

17

65–79

LEVCEEQKCEEEVFP

42

165–179

LSKMPEAEENKQIIR

67

265–279

NMDPKAAEEEEEEEE

18

69–83

EEQKCEEEVFPLAMN

43

169–183

PEAEENKQIIRKHAQ

68

269–283

KAAEEEEEEEEEVDL

19

73–87

CEEEVFPLAMNYLDR

44

173–187

ENKQIIRKHAQTFVA

69

273–287

EEEEEEEEVDLACTP

20

77–91

VFPLAMNYLDRFLSL

45

177–191

IIRKHAQTFVALCAT

70

277–291

EEEEVDLACTPTDVR

21

84–95

AMNYLDRFLSLEPVK

46

181–195

HAQTFVALCATDVKF

71

281–295

VDLACTPTDVRDVDI

22

85–99

LDRFLSLEPVKKSRL

47

185–199

FVALCATDVKFISNP

23

89–103

LSLEPVKKSRLQLLG

48

189–203

CATDVKFISNPPSMV

24

93–107

PVKKSRLQLLGATCM

49

193–207

VKFISNPPSMVAAGS

25

97–111

SRLQLLGATCMFVAS

50

197–211

SNPPSMVAAGSVVAA